» Articles » PMID: 30153830

Prevalence and Incidence of Sarcoidosis in Korea: a Nationwide Population-based Study

Overview
Journal Respir Res
Specialty Pulmonary Medicine
Date 2018 Aug 30
PMID 30153830
Citations 25
Authors
Affiliations
Soon will be listed here.
Abstract

Background: The prevalence and incidence of sarcoidosis varies worldwide. We estimated the prevalence and incidence of sarcoidosis in Korea using nationwide claims data from the Korean Health Insurance Review and Assessment Service.

Methods: Cases of sarcoidosis were identified for any visit between 2007 to 2016 that listed the Korean Classification of Disease, 7th edition code of sarcoidosis and rare incurable disease exempted calculation code. A narrow case definition was used as follows: 1) ≥ two sarcoidosis-coded visits within 1 year of the first claim, 2) no claims for other diseases that could form granuloma.

Results: A total of 4791 patients (narrow, n = 2388) visited medical institutions for sarcoidosis during the study period; 2999 patients (narrow, n = 1696) were newly identified between 2009 and 2015. The sarcoidosis prevalence was 9.37 per 10 people (narrow, 4.69) and was highest between ages 60-69 years. The incidence rate was 0.85 per 10 population at risk (narrow, 0.48), with the highest incidence rate between ages 50-59 years. For incident cases (mean age: 48.5 year), the age distribution in whole population and females showed monophasic patterns peaking at aged 50-59 years, while males had biphasic incidence peak at aged 30-39 years and 60-69 years. The annual incidence rates showed increasing trends from 0.85 per 10 population at risk in 2009 to 0.97 per 10 population at risk in 2015.

Conclusions: In comparison with previous reports, the prevalence and incidence of sarcoidosis in Korea have increased and middle-aged women showed the highest risk.

Citing Articles

Contemporary Diagnostics of Cardiac Sarcoidosis: The Importance of Multimodality Imaging.

Stjepanovic M, Markovic F, Milivojevic I, Popevic S, Dimic-Janjic S, Popadic V Diagnostics (Basel). 2024; 14(17).

PMID: 39272650 PMC: 11394254. DOI: 10.3390/diagnostics14171865.


Impact of the coronavirus disease 2019 pandemic on hospital admissions for idiopathic pulmonary fibrosis: a nationwide population-based study.

Cho I, Lim J, Chang M, Lee J BMC Pulm Med. 2024; 24(1):430.

PMID: 39217306 PMC: 11365253. DOI: 10.1186/s12890-024-03230-3.


National retrospective registry survey on the epidemiology of sarcoidosis in Finland 2002-2022.

Salonen J, Kaarteenaho R BMJ Open Respir Res. 2024; 11(1).

PMID: 39174054 PMC: 11340709. DOI: 10.1136/bmjresp-2024-002461.


Identifying sarcoidosis trends using web search and real-world data in Sweden: a retrospective longitudinal study.

Ziehfreund S, Tizek L, Arkema E, Zink A Sci Rep. 2024; 14(1):19260.

PMID: 39164281 PMC: 11335935. DOI: 10.1038/s41598-024-69223-8.


A young male with non-resolving consolidation and hepatosplenomegaly.

Bajad P, Pahuja S, Agarwal S, Khanna G, Khanna A Lung India. 2024; 41(4):299-304.

PMID: 38953194 PMC: 11302775. DOI: 10.4103/lungindia.lungindia_417_23.


References
1.
Hattori T, Konno S, Shijubo N, Ohmichi M, Yamaguchi T, Nishimura M . Resolution rate of pulmonary sarcoidosis and its related factors in a Japanese population. Respirology. 2017; 22(8):1604-1608. DOI: 10.1111/resp.13105. View

2.
Deubelbeiss U, Gemperli A, Schindler C, Baty F, Brutsche M . Prevalence of sarcoidosis in Switzerland is associated with environmental factors. Eur Respir J. 2009; 35(5):1088-97. DOI: 10.1183/09031936.00197808. View

3.
Baughman R, Judson M, Teirstein A, Yeager H, Rossman M, Knatterud G . Presenting characteristics as predictors of duration of treatment in sarcoidosis. QJM. 2006; 99(5):307-15. DOI: 10.1093/qjmed/hcl038. View

4.
Gribbin J, Hubbard R, Le Jeune I, Smith C, West J, Tata L . Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax. 2006; 61(11):980-5. PMC: 2121155. DOI: 10.1136/thx.2006.062836. View

5.
Kim M, Park C, Shin H, Seo H, Chang J, Ahn S . Review of Sarcoidosis in a Province of South Korea from 1996 to 2014. Tuberc Respir Dis (Seoul). 2017; 80(3):291-295. PMC: 5526957. DOI: 10.4046/trd.2017.80.3.291. View